rs2280738

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_013372.7(GREM1):​c.207C>G​(p.Pro69Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0186 in 1,613,540 control chromosomes in the GnomAD database, including 1,320 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P69P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.022 ( 164 hom., cov: 32)
Exomes 𝑓: 0.018 ( 1156 hom. )

Consequence

GREM1
NM_013372.7 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -9.53

Publications

12 publications found
Variant links:
Genes affected
GREM1 (HGNC:2001): (gremlin 1, DAN family BMP antagonist) This gene encodes a member of the BMP (bone morphogenic protein) antagonist family. Like BMPs, BMP antagonists contain cystine knots and typically form homo- and heterodimers. The CAN (cerberus and dan) subfamily of BMP antagonists, to which this gene belongs, is characterized by a C-terminal cystine knot with an eight-membered ring. The antagonistic effect of the secreted glycosylated protein encoded by this gene is likely due to its direct binding to BMP proteins. As an antagonist of BMP, this gene may play a role in regulating organogenesis, body patterning, and tissue differentiation. In mouse, this protein has been shown to relay the sonic hedgehog (SHH) signal from the polarizing region to the apical ectodermal ridge during limb bud outgrowth. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
GREM1 Gene-Disease associations (from GenCC):
  • hereditary mixed polyposis syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • polyposis syndrome, hereditary mixed, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_013372.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 15-32730897-C-G is Benign according to our data. Variant chr15-32730897-C-G is described in ClinVar as Benign. ClinVar VariationId is 402911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-9.53 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.204 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_013372.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GREM1
NM_013372.7
MANE Select
c.207C>Gp.Pro69Pro
synonymous
Exon 2 of 2NP_037504.1A6XAA7
GREM1
NM_001368719.1
c.207C>Gp.Pro69Pro
synonymous
Exon 2 of 2NP_001355648.1O60565-1
GREM1
NM_001191323.2
c.115-31C>G
intron
N/ANP_001178252.1O60565-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GREM1
ENST00000651154.1
MANE Select
c.207C>Gp.Pro69Pro
synonymous
Exon 2 of 2ENSP00000498748.1O60565-1
GREM1
ENST00000560677.5
TSL:4
c.105-19C>G
intron
N/AENSP00000453387.1H0YLY2
GREM1
ENST00000652365.1
c.207C>Gp.Pro69Pro
synonymous
Exon 2 of 2ENSP00000498763.1O60565-1

Frequencies

GnomAD3 genomes
AF:
0.0216
AC:
3279
AN:
152076
Hom.:
164
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0148
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00864
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.215
Gnomad SAS
AF:
0.0781
Gnomad FIN
AF:
0.0382
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00756
Gnomad OTH
AF:
0.0230
GnomAD2 exomes
AF:
0.0358
AC:
8891
AN:
248442
AF XY:
0.0373
show subpopulations
Gnomad AFR exome
AF:
0.0153
Gnomad AMR exome
AF:
0.00719
Gnomad ASJ exome
AF:
0.0261
Gnomad EAS exome
AF:
0.211
Gnomad FIN exome
AF:
0.0402
Gnomad NFE exome
AF:
0.00759
Gnomad OTH exome
AF:
0.0268
GnomAD4 exome
AF:
0.0183
AC:
26674
AN:
1461346
Hom.:
1156
Cov.:
33
AF XY:
0.0200
AC XY:
14530
AN XY:
726928
show subpopulations
African (AFR)
AF:
0.0157
AC:
527
AN:
33480
American (AMR)
AF:
0.00772
AC:
345
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0241
AC:
630
AN:
26104
East Asian (EAS)
AF:
0.180
AC:
7158
AN:
39700
South Asian (SAS)
AF:
0.0782
AC:
6738
AN:
86206
European-Finnish (FIN)
AF:
0.0383
AC:
2037
AN:
53188
Middle Eastern (MID)
AF:
0.0149
AC:
86
AN:
5766
European-Non Finnish (NFE)
AF:
0.00667
AC:
7419
AN:
1111820
Other (OTH)
AF:
0.0287
AC:
1734
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1572
3144
4717
6289
7861
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
486
972
1458
1944
2430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0216
AC:
3295
AN:
152194
Hom.:
164
Cov.:
32
AF XY:
0.0246
AC XY:
1832
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0151
AC:
628
AN:
41538
American (AMR)
AF:
0.00863
AC:
132
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
77
AN:
3472
East Asian (EAS)
AF:
0.215
AC:
1105
AN:
5150
South Asian (SAS)
AF:
0.0786
AC:
379
AN:
4822
European-Finnish (FIN)
AF:
0.0382
AC:
405
AN:
10602
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00756
AC:
514
AN:
68008
Other (OTH)
AF:
0.0242
AC:
51
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
154
309
463
618
772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0121
Hom.:
13
Bravo
AF:
0.0193
Asia WGS
AF:
0.126
AC:
439
AN:
3478
EpiCase
AF:
0.00736
EpiControl
AF:
0.00693

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.0030
DANN
Benign
0.73
PhyloP100
-9.5
BranchPoint Hunter
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2280738;
hg19: chr15-33023098;
COSMIC: COSV55714571;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.